+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Monitoring Market by Application, End User, Product Type, Distribution Channel - Global Forecast to 2030- Product Image
Blood Glucose Monitoring Market by Application, End User, Product Type, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Blood Glucose Monitoring Market by Application, End User, Product Type, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666055
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Monitoring Market grew from USD 14.08 billion in 2024 to USD 15.27 billion in 2025. It is expected to continue growing at a CAGR of 8.38%, reaching USD 22.82 billion by 2030.

Setting the Stage for Glucose Monitoring Innovation

The global blood glucose monitoring arena stands at a pivotal crossroads, shaped by shifting demographics, evolving regulatory environments, and technological breakthroughs. Rising incidence of diabetes worldwide has amplified demand for accurate, user-friendly monitoring solutions that support both clinical decision-making and patient self-management. This landscape demands a clear understanding of emerging trends, growth drivers, and potential barriers to adoption.

In this report, we unpack the critical factors propelling the market forward, including advances in sensor technology, digital health integration, and shifting reimbursement policies. By situating these dynamics within the broader context of chronic disease management and healthcare delivery, readers will gain a foundational perspective on how the industry is adapting to the needs of patients, providers, and payers alike.

Revolutionary Forces Reshaping Glucose Monitoring

Recent years have witnessed transformative forces that are redefining the blood glucose monitoring landscape. Artificial intelligence-driven analytics now enable richer, real-time insights from continuous glucose monitoring data, empowering clinicians to tailor treatment regimens with unprecedented precision. Simultaneously, the convergence of telehealth platforms and wearable sensors has created a seamless continuum of care, extending monitoring capabilities beyond traditional clinical settings.

Meanwhile, the race toward noninvasive and minimally invasive technologies has accelerated, spurred by patient demand for greater convenience and comfort. Regulatory bodies have also adapted, streamlining pathways for breakthrough devices while reinforcing post-market surveillance to ensure safety and efficacy. These collective shifts are not only expanding the scope of monitoring solutions, but also transforming patient engagement, clinical workflows, and the economics of diabetes care.

Assessing the Ripple Effects of 2025 US Tariff Adjustments

The introduction of new tariffs on imported glucose monitoring supplies in 2025 has introduced a complex set of challenges for manufacturers and distributors. Increased import duties on sensors, test strips, and control solutions have driven up production costs, compelling many stakeholders to revisit their supply chain strategies. As manufacturers explore regionalized manufacturing hubs, distribution networks have realigned to mitigate cost pressures while preserving product availability.

This tariff regime has also influenced device pricing dynamics, with end users facing marginally higher out-of-pocket expenses in certain markets. Industry players are responding through strategic partnerships and localized assembly agreements designed to offset tariff impacts. Regulatory agencies and purchasing organizations are exercising closer procurement scrutiny, emphasizing total cost of ownership and long-term value of advanced monitoring solutions.

Diving into Market Segments for Targeted Growth

In examining market segmentation, several distinct patterns emerge. Application based analysis reveals that Type 2 Diabetes constitutes the largest share of monitoring utilization, followed by expanding gestational diabetes screening programs and steady uptake among Type 1 patients. End user segmentation highlights a shift toward home care as patient self-monitoring gains traction, even as ambulatory care centers and hospitals remain critical nodes for high-acuity monitoring needs. Diagnostic laboratories continue to play a supportive role in confirmatory testing and specialized analytics.

Product type segmentation underscores the rapid ascent of continuous glucose monitoring systems, with real‐time devices gaining ground over intermittently scanned offerings due to their predictive alerts and data-sharing capabilities. Self-monitoring devices maintain a strong presence, driven by traditional glucose meters, test strips, and ancillary items such as lancing devices and control solutions. Distribution channels reflect an omnichannel approach: hospitals and clinics serve acute care demand, while online retail platforms and pharmacies deliver convenience and accessibility for ongoing patient use.

Unveiling Regional Dynamics Driving Market Momentum

Regional dynamics exert a profound influence on market opportunity and competitive strategy. In the Americas, high prevalence rates paired with established reimbursement frameworks fuel robust demand for both advanced continuous monitoring systems and cost-effective self-monitoring solutions. Latin American markets are gaining momentum as public health initiatives prioritize diabetes screening and preventive care.

Across Europe, the Middle East, and Africa, heterogeneous regulatory landscapes shape adoption patterns. Western Europe exhibits high penetration of cutting‐edge devices supported by progressive health technology assessments, whereas select Middle Eastern and African nations are beginning to leverage partnerships and subsidies to expand access. In the Asia-Pacific region, government-led diabetes programs and rising disposable incomes are catalyzing uptake of remote monitoring technologies, with local manufacturers increasingly participating through strategic alliances and tailored product offerings.

Profiling Leading Innovators and Market Drivers

The competitive field is anchored by several industry stalwarts and emerging challengers. Leading innovators such as Abbott and Dexcom continue to extend their portfolios with next-generation sensors and integrated digital platforms that enhance data-driven care. Medtronic pursues convergence of insulin delivery systems and glucose monitoring into unified closed-loop solutions, while Roche and LifeScan maintain strong footholds in self-monitoring with upgrades in meter accuracy and user interface.

New entrants and tech alliances are also reshaping competitive dynamics. Partnerships between device manufacturers and software developers have accelerated the creation of interoperable ecosystems, enabling seamless data sharing across electronic health records and consumer health apps. Smaller regional players are carving niche positions by focusing on cost-effective distribution strategies and localized customer support, ensuring broader reach in price-sensitive markets.

Strategic Imperatives for Seizing Market Leadership

Industry leaders must adopt a multifaceted strategy to sustain growth and market share. Investing in noninvasive sensor research and embracing artificial intelligence enhancements can differentiate offerings and deliver superior patient experiences. Expanding presence in emerging markets through strategic local partnerships and cost-effective distribution models will capture untapped demand, while simultaneously navigating regional regulatory requirements.

In parallel, forging alliances with telehealth providers and payers can unlock value-based reimbursement pathways, ensuring that advanced monitoring solutions demonstrate measurable outcomes. Enhancing patient education programs and leveraging data analytics to inform personalized care plans will drive higher engagement and adherence. Finally, maintaining agility in supply chain management-through diversified sourcing and regional manufacturing-will mitigate tariff risks and support responsive product rollouts.

Robust Methodology Underpinning Our Insights

This report is founded on a rigorous research framework combining comprehensive secondary data analysis with targeted primary interviews. Global market data, regulatory filings, corporate annual reports, and peer-reviewed literature were systematically reviewed to establish baseline trends. Complementing this, in-depth discussions with industry executives, clinical specialists, and payers provided firsthand perspectives on market dynamics and emerging opportunities.

Quantitative data was triangulated through cross‐validation against historical performance indicators and regional health statistics. Segmentation parameters were defined to reflect both product characteristics and end-user contexts, ensuring that analytical models account for nuanced adoption patterns. Throughout the process, methodological safeguards-including consistency checks and peer reviews-ensured the reliability and validity of findings.

Concluding Reflections on the Future of Glucose Monitoring

As the blood glucose monitoring market evolves, the convergence of technology, policy, and patient-centric care models will continue to drive innovation and reshuffle competitive hierarchies. Stakeholders equipped with a clear understanding of segmentation nuances, regional priorities, and tariff implications will be best positioned to capture growth and deliver meaningful health outcomes.

The path forward demands collaboration across manufacturers, healthcare providers, regulatory bodies, and payers to foster ecosystems that prioritize accuracy, affordability, and accessibility. By aligning strategic investments with data-driven insights, the industry can accelerate progress toward a future where real-time, personalized glucose monitoring is an integral part of comprehensive chronic disease management.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Gestational Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • End User
    • Ambulatory Care
    • Diagnostic Laboratories
    • Home Care
    • Hospitals
  • Product Type
    • Continuous Glucose Monitoring Systems
      • Intermittently Scanned Systems
      • Real Time Continuous Systems
    • Self Monitoring Devices
      • Control Solutions
      • Glucose Meters
      • Lancing Devices
      • Test Strips
  • Distribution Channel
    • Hospitals Clinics
    • Online Retailers
    • Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • Dexcom, Inc.
  • LifeScan, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Medtronic plc
  • Becton, Dickinson and Company
  • Nova Biomedical Corporation
  • Nipro Corporation
  • Sinocare, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Glucose Monitoring Market, by Application
8.1. Introduction
8.2. Gestational Diabetes
8.3. Type 1 Diabetes
8.4. Type 2 Diabetes
9. Blood Glucose Monitoring Market, by End User
9.1. Introduction
9.2. Ambulatory Care
9.3. Diagnostic Laboratories
9.4. Home Care
9.5. Hospitals
10. Blood Glucose Monitoring Market, by Product Type
10.1. Introduction
10.2. Continuous Glucose Monitoring Systems
10.2.1. Intermittently Scanned Systems
10.2.2. Real Time Continuous Systems
10.3. Self Monitoring Devices
10.3.1. Control Solutions
10.3.2. Glucose Meters
10.3.3. Lancing Devices
10.3.4. Test Strips
11. Blood Glucose Monitoring Market, by Distribution Channel
11.1. Introduction
11.2. Hospitals Clinics
11.3. Online Retailers
11.4. Pharmacies
12. Americas Blood Glucose Monitoring Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood Glucose Monitoring Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood Glucose Monitoring Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Diagnostics International AG
15.3.2. Abbott Laboratories
15.3.3. Dexcom, Inc.
15.3.4. LifeScan, Inc.
15.3.5. Ascensia Diabetes Care Holdings AG
15.3.6. Medtronic plc
15.3.7. Becton, Dickinson and Company
15.3.8. Nova Biomedical Corporation
15.3.9. Nipro Corporation
15.3.10. Sinocare, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD GLUCOSE MONITORING MARKET MULTI-CURRENCY
FIGURE 2. BLOOD GLUCOSE MONITORING MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INTERMITTENTLY SCANNED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REAL TIME CONTINUOUS SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTROL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 48. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 49. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 86. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 103. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 104. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 109. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 110. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 134. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 145. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 146. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 152. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 170. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 175. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 176. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 187. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 188. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 194. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 212. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 213. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 218. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 219. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 225. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 249. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 281. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Blood Glucose Monitoring market report include:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • Dexcom, Inc.
  • LifeScan, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Medtronic plc
  • Becton, Dickinson and Company
  • Nova Biomedical Corporation
  • Nipro Corporation
  • Sinocare, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 15.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.82 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Continuous Blood Glucose Monitoring Systems Market by Technology, Product, End User, Distribution Channel, Application - Global Forecast to 2030 - Product Image

Continuous Blood Glucose Monitoring Systems Market by Technology, Product, End User, Distribution Channel, Application - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Smart Blood Glucose Monitoring Device Market by Product Type, End User, Technology, Application, Distribution Channel - Global Forecast to 2030 - Product Image

Smart Blood Glucose Monitoring Device Market by Product Type, End User, Technology, Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Blood Glucose Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Blood Glucose Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Blood Glucose Monitoring Systems - Global Strategic Business Report - Product Image

Blood Glucose Monitoring Systems - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029 - Product Image

Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029

  • Report
  • 160 Pages
  • Global
From

About the Blood Glucose Monitoring Market

The Blood Glucose Monitoring market is a subset of the Glucose Testing market, which is used to measure the amount of glucose in the blood. Blood Glucose Monitoring is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to monitor glucose levels in people with other medical conditions, such as kidney disease. Blood Glucose Monitoring is typically done using a glucometer, which is a device that measures the amount of glucose in a sample of blood. The glucometer is usually used in conjunction with a test strip, which is a disposable strip that is used to collect a sample of blood. Some companies in the Blood Glucose Monitoring market include Abbott Laboratories, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.